Sicor Inc.:

The Irvine specialty pharmaceutical company said net income for the second quarter totaled $6.9 million, or 7 cents a share. That compares with net income of $284,000 for the comparable quarter of 1999, which included charges of $1.8 million relating to the divestiture of a partial interest in Metabasis Therapeutics Inc. Revenue increased 31% to $71.8 million.